ECP
APSG.WS

Empyrean Capital Partners’s Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer APSG.WS Stock Holding History

Empyrean Capital Partners’s Portfolio APSG.WS Stock Details APSG.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,165,660
Closed -$1.6M – 202
2022
Q1 		$1.6M Hold
1,165,660
– – 0.04% 142
2021
Q4 		$1.49M Hold
1,165,660
– – 0.04% 136
2021
Q3 		$950K Hold
1,165,660
– – 0.02% 146
2021
Q2 		$1.39M Hold
1,165,660
– – 0.03% 154
2021
Q1 		$1.47M Hold
1,165,660
– – 0.04% 133
2020
Q4 		$2.19M Buy
+1,165,660
New +$1.83M 0.07% 108

Empyrean Capital Partners's APSG.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer (APSG.WS) in Q2 2022, closing a stake of 1,165,660 shares — an estimated $1.6M sold.

Empyrean Capital Partners first reported a position in APSG.WS in Q4 2020 and held it in 6 quarters. The position peaked at $2.19M in Q4 2020. 0 funds tracked by Wall St. Rank hold APSG.WS as of Q2 2022.

  • Empyrean Capital Partners reported no remaining Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,165,660 Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer shares in Q2 2022, an estimated $1.6M.
  • Empyrean Capital Partners first reported a position in Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer in Q4 2020 and held it in 6 quarters.
  • Empyrean Capital Partners's Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position peaked at $2.19M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.